Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.08 USD | +2.46% | +8.33% | +18.18% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 102M |
---|---|---|---|---|---|
Net income 2024 * | -33M | Net income 2025 * | -45M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-4.08
x | P/E ratio 2025 * |
-3.7
x | Employees | 28 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.74% |
Latest transcript on Corvus Pharmaceuticals, Inc.
1 day | +2.46% | ||
1 week | +8.33% | ||
Current month | +34.19% | ||
1 month | +37.75% | ||
3 months | -6.09% | ||
6 months | +49.64% | ||
Current year | +18.18% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 14-01-26 |
Leiv Lea
DFI | Director of Finance/CFO | 70 | 14-01-26 |
James Rosenbaum
CTO | Chief Tech/Sci/R&D Officer | - | 22-07-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 14-01-26 |
Ian Clark
BRD | Director/Board Member | 62 | 17-01-02 |
Terry Gould
BRD | Director/Board Member | 67 | 14-10-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 2.08 | +2.46% | 307,162 |
24-05-09 | 2.03 | +3.57% | 677,052 |
24-05-08 | 1.96 | +16.67% | 658,504 |
24-05-07 | 1.68 | -12.04% | 1,018,040 |
24-05-06 | 1.91 | -0.52% | 1,050,436 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.18% | 102M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- CRVS Stock